GlyCosmos Glycoproteins

Integrated list of glycoproteins extracted from UniProt and annotated with glycosylation data from GlyGen and GlyConnect. For each entry, information such as glycosylation site, glycans, diseases, 3D structures, and pathway information are available.

Database Last Updated
GlyConnect April 19, 2023
GlycoProtDB October 1, 2021
GlyGen October 2, 2023
Human Protein Atlas June 19, 2023 (Protein Atlas version 23)
MCAW-DB July 10, 2019
The O-GlcNAc Database April 10, 2023 (v1.3)
Reactome February 28, 2024 (Version 87)
UniProt December 27, 2023
Protein Name ▲ UniProt ID Gene Symbol Species Taxonomy ID No. of Glycosylation Sites GO Labels GO IDs
  • Tc00.1047053507047.110
353153
  • cysteine-type deubiquitinase activity
  • proteolysis
  • GO:0004843
  • GO:0006508
  • Usp16
10090
2
  • cysteine-type deubiquitinase activity
  • proteolysis
  • zinc ion binding
  • GO:0004843
  • GO:0006508
  • GO:0008270
  • Tnfaip3
10116
  • B-1 B cell homeostasis
  • DNA binding
  • K63-linked deubiquitinase activity
  • K63-linked polyubiquitin modification-dependent protein binding
  • cell migration
  • cellular response to hydrogen peroxide
  • cellular response to lipopolysaccharide
  • cysteine-type deubiquitinase activity
  • cytoplasm
  • cytoskeleton organization
  • establishment of protein localization to vacuole
  • identical protein binding
  • kinase binding
  • negative regulation of B cell activation
  • negative regulation of CD40 signaling pathway
  • negative regulation of canonical NF-kappaB signal transduction
  • negative regulation of chronic inflammatory response
  • negative regulation of endothelial cell apoptotic process
  • negative regulation of extrinsic apoptotic signaling pathway
  • negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
  • negative regulation of inflammatory response
  • negative regulation of innate immune response
  • negative regulation of interleukin-1 beta production
  • negative regulation of interleukin-2 production
  • negative regulation of interleukin-6 production
  • negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway
  • negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway
  • negative regulation of protein ubiquitination
  • negative regulation of smooth muscle cell proliferation
  • negative regulation of toll-like receptor 3 signaling pathway
  • negative regulation of toll-like receptor 5 signaling pathway
  • negative regulation of tumor necrosis factor production
  • nucleus
  • positive regulation of Wnt signaling pathway
  • positive regulation of hepatocyte proliferation
  • positive regulation of protein catabolic process
  • protease binding
  • protein self-association
  • proteolysis
  • regulation of germinal center formation
  • response to molecule of bacterial origin
  • response to muramyl dipeptide
  • tolerance induction to lipopolysaccharide
  • ubiquitin binding
  • ubiquitin-protein transferase activity
  • zinc ion binding
  • GO:0001922
  • GO:0002020
  • GO:0002237
  • GO:0002634
  • GO:0002677
  • GO:0003677
  • GO:0004842
  • GO:0004843
  • GO:0005634
  • GO:0005737
  • GO:0006508
  • GO:0007010
  • GO:0008270
  • GO:0016477
  • GO:0019900
  • GO:0030177
  • GO:0031397
  • GO:0032495
  • GO:0032691
  • GO:0032703
  • GO:0032715
  • GO:0032720
  • GO:0034140
  • GO:0034148
  • GO:0042802
  • GO:0043124
  • GO:0043130
  • GO:0043621
  • GO:0045732
  • GO:0045824
  • GO:0048662
  • GO:0050728
  • GO:0050869
  • GO:0061578
  • GO:0070301
  • GO:0070429
  • GO:0070433
  • GO:0070530
  • GO:0071222
  • GO:0072573
  • GO:0072666
  • GO:1902042
  • GO:2000347
  • GO:2000349
  • GO:2000352
  • GO:2001237
  • Otud4
10090
  • cysteine-type deubiquitinase activity
  • proteolysis
  • GO:0004843
  • GO:0006508
  • Usp31
10090
  • cysteine-type deubiquitinase activity
  • nucleus
  • proteolysis
  • GO:0004843
  • GO:0005634
  • GO:0006508
  • Tnfaip3
10116
  • B-1 B cell homeostasis
  • DNA binding
  • K63-linked deubiquitinase activity
  • K63-linked polyubiquitin modification-dependent protein binding
  • cell migration
  • cellular response to hydrogen peroxide
  • cellular response to lipopolysaccharide
  • cysteine-type deubiquitinase activity
  • cytoplasm
  • cytoskeleton organization
  • establishment of protein localization to vacuole
  • identical protein binding
  • kinase binding
  • negative regulation of B cell activation
  • negative regulation of CD40 signaling pathway
  • negative regulation of canonical NF-kappaB signal transduction
  • negative regulation of chronic inflammatory response
  • negative regulation of endothelial cell apoptotic process
  • negative regulation of extrinsic apoptotic signaling pathway
  • negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
  • negative regulation of inflammatory response
  • negative regulation of innate immune response
  • negative regulation of interleukin-1 beta production
  • negative regulation of interleukin-2 production
  • negative regulation of interleukin-6 production
  • negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway
  • negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway
  • negative regulation of protein ubiquitination
  • negative regulation of smooth muscle cell proliferation
  • negative regulation of toll-like receptor 3 signaling pathway
  • negative regulation of toll-like receptor 5 signaling pathway
  • negative regulation of tumor necrosis factor production
  • nucleus
  • positive regulation of Wnt signaling pathway
  • positive regulation of hepatocyte proliferation
  • positive regulation of protein catabolic process
  • protease binding
  • protein self-association
  • proteolysis
  • regulation of germinal center formation
  • response to molecule of bacterial origin
  • response to muramyl dipeptide
  • tolerance induction to lipopolysaccharide
  • ubiquitin binding
  • ubiquitin-protein transferase activity
  • zinc ion binding
  • GO:0001922
  • GO:0002020
  • GO:0002237
  • GO:0002634
  • GO:0002677
  • GO:0003677
  • GO:0004842
  • GO:0004843
  • GO:0005634
  • GO:0005737
  • GO:0006508
  • GO:0007010
  • GO:0008270
  • GO:0016477
  • GO:0019900
  • GO:0030177
  • GO:0031397
  • GO:0032495
  • GO:0032691
  • GO:0032703
  • GO:0032715
  • GO:0032720
  • GO:0034140
  • GO:0034148
  • GO:0042802
  • GO:0043124
  • GO:0043130
  • GO:0043621
  • GO:0045732
  • GO:0045824
  • GO:0048662
  • GO:0050728
  • GO:0050869
  • GO:0061578
  • GO:0070301
  • GO:0070429
  • GO:0070433
  • GO:0070530
  • GO:0071222
  • GO:0072573
  • GO:0072666
  • GO:1902042
  • GO:2000347
  • GO:2000349
  • GO:2000352
  • GO:2001237
  • Usp36
10090
  • cysteine-type deubiquitinase activity
  • proteolysis
  • GO:0004843
  • GO:0006508
  • Uchl5
10090
  • Ino80 complex
  • cysteine-type deubiquitinase activity
  • proteasome binding
  • ubiquitin-dependent protein catabolic process
  • GO:0004843
  • GO:0006511
  • GO:0031011
  • GO:0070628
  • Tc00.1047053504045.110
353153
  • histidine catabolic process to glutamate and formamide
  • histidine catabolic process to glutamate and formate
  • urocanate hydratase activity
  • GO:0016153
  • GO:0019556
  • GO:0019557
  • TCDM_03985
1416333
  • histidine catabolic process to glutamate and formamide
  • histidine catabolic process to glutamate and formate
  • transaminase activity
  • urocanate hydratase activity
  • GO:0008483
  • GO:0016153
  • GO:0019556
  • GO:0019557
Displaying entries 120161 - 120170 of 120208 in total

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01